{"date":"2025-07-29","count":32,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6649-2025-07-29-2237-1tkkj4d","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2025-07-29","time":"22:37:13","subject":"公告本公司114年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2025-07-29 22:37，「公告本公司114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4153-2025-07-29-1727-aa2zln","company_id":"4153","company":"鈺緯","market":"上櫃","industry":"生技醫療","date":"2025-07-29","time":"17:27:09","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：鈺緯（4153），2025-07-29 17:27，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2025-07-29-1724-1qmvxx5","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2025-07-29","time":"17:24:10","subject":"公告114年第2季合併財務報告董事會預計召開日期為114年8月6日","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2025-07-29 17:24，「公告114年第2季合併財務報告董事會預計召開日期為114年8月6日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2025-07-29-1720-3skf24","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2025-07-29","time":"17:20:08","subject":"公告本公司114年第2季財務報告董事會預計召開日期為114年8月6日","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2025-07-29 17:20，「公告本公司114年第2季財務報告董事會預計召開日期為114年8月6日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-07-29-1717-57zjbn","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-07-29","time":"17:17:35","subject":"公告本公司副總經理異動","clause":"第11款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-07-29 17:17，「公告本公司副總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-07-29-1709-1orhu4z","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-07-29","time":"17:09:25","subject":"公告本公司修訂國內第五次無擔保轉換公司債發行及轉換辦法業經金融監督管理委員會核准","clause":"第51款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-07-29 17:09，「公告本公司修訂國內第五次無擔保轉換公司債發行及轉換辦法業經金融監督管理委員會核准」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-07-29-1709-1xn02un","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-07-29","time":"17:09:02","subject":"公告本公司114年第二季合併財務報告預計經董事會決議日","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-07-29 17:09，「公告本公司114年第二季合併財務報告預計經董事會決議日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-07-29-1656-1g5rdoi","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-07-29","time":"16:56:00","subject":"公告本公司第四屆薪酬委員會委員任期屆滿","clause":"第6款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-07-29 16:56，「公告本公司第四屆薪酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-07-29-1655-9pzrnm","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-07-29","time":"16:55:29","subject":"公告本公司一一四年第一次股東臨時會決議解除第十二屆新任董事(含獨立董事)及其代表人競業禁止之限制案","clause":"第22款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-07-29 16:55，「公告本公司一一四年第一次股東臨時會決議解除第十二屆新任董事(含獨立董事)及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-07-29-1654-11w1ecs","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-07-29","time":"16:54:20","subject":"公告本公司一一四年第一次股東臨時會全面改選董事(含獨立董事)當選名單暨董事變動達三分之一","clause":"第6款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-07-29 16:54，「公告本公司一一四年第一次股東臨時會全面改選董事(含獨立董事)當選名單暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2025-07-29-1650-10vwl69","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2025-07-29","time":"16:50:31","subject":"公告本公司114年第二季合併財務報告董事會預計召開日期為114年08月06日","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2025-07-29 16:50，「公告本公司114年第二季合併財務報告董事會預計召開日期為114年08月06日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-07-29-1647-7o0cmw","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-07-29","time":"16:47:18","subject":"代子公司:Hong Kong Chlitina International Limited、(BVI) Chlitina International Limited及(BVI) ChlitinaGroup Limited等子公司公告決議配發現金股息之相關事宜","clause":"第14款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-07-29 16:47，「代子公司:Hong Kong Chlitina International Limited、(BVI) Chlitina」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2025-07-29-1634-87qz4w","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2025-07-29","time":"16:34:09","subject":"公告本公司114年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2025-07-29 16:34，「公告本公司114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2025-07-29-1625-1mqtn15","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-07-29","time":"16:25:23","subject":"公告本公司董事會決議除息基準日事宜","clause":"第14款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-07-29 16:25，「公告本公司董事會決議除息基準日事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2025-07-29-1623-jzg4w5","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-07-29","time":"16:23:45","subject":"公告本公司114年第二季財務報告","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-07-29 16:23，「公告本公司114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8279-2025-07-29-1621-1p3d51","company_id":"8279","company":"生展","market":"上櫃","industry":"生技醫療","date":"2025-07-29","time":"16:21:19","subject":"公告本公司董事會決議通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：生展（8279），2025-07-29 16:21，「公告本公司董事會決議通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-07-29-1614-1ok6q8r","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-07-29","time":"16:14:22","subject":"公告本公司開發之臍帶間質幹細胞外泌體藥物原料UCMSC Exosomes已獲美FDA原料藥主檔案(DMF)登記申請核可","clause":"第44款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-07-29 16:14，「公告本公司開發之臍帶間質幹細胞外泌體藥物原料UCMSC Exosomes已獲美FDA原料藥主檔案(DMF)登記申請核可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-07-29-1612-13gqnh4","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-07-29","time":"16:12:45","subject":"公告本公司114年度第二季合併財務報告預計提報董事會日期","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-07-29 16:12，「公告本公司114年度第二季合併財務報告預計提報董事會日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2025-07-29-1607-4v7nev","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2025-07-29","time":"16:07:37","subject":"代重要子公司曜胜生技股份有限公司公告董事會決議變更本公司營業地址","clause":"第53款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2025-07-29 16:07，「代重要子公司曜胜生技股份有限公司公告董事會決議變更本公司營業地址」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-07-29-1601-1jk2559","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-29","time":"16:01:23","subject":"公告本公司與Kohjin Bio及宏騏實業簽署三方合作備忘錄(MOU)共同開發客製化細胞培養基計畫","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-07-29 16:01，「公告本公司與Kohjin Bio及宏騏實業簽署三方合作備忘錄(MOU)共同開發客製化細胞培養基計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-07-29-1549-10vwl69","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-07-29","time":"15:49:41","subject":"公告本公司114年第二季合併財務報告董事會預計召開日期為114年08月06日","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-07-29 15:49，「公告本公司114年第二季合併財務報告董事會預計召開日期為114年08月06日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-07-29-1531-54swv6","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-07-29","time":"15:31:42","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-07-29 15:31，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2025-07-29-1525-11h4c7m","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2025-07-29","time":"15:25:45","subject":"公告本公司民國114年第二季財務報告董事會預計召開日期為114年8月6日","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2025-07-29 15:25，「公告本公司民國114年第二季財務報告董事會預計召開日期為114年8月6日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-29-1515-b92wza","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-29","time":"15:15:05","subject":"公告本公司114年度第二季財務報告董事會預計召開日期為114年08月06日","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-29 15:15，「公告本公司114年度第二季財務報告董事會預計召開日期為114年08月06日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-07-29-1508-7rzr08","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-07-29","time":"15:08:09","subject":"公告本公司法人董事指派代表人","clause":"第6款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-07-29 15:08，「公告本公司法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-07-29-1505-gptltd","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-07-29","time":"15:05:24","subject":"公告本公司第十二屆董事會通過董事長選任案","clause":"第6款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-07-29 15:05，「公告本公司第十二屆董事會通過董事長選任案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-07-29-1504-1j7u2pb","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-07-29","time":"15:04:26","subject":"公告本公司第五屆審計委員會委員","clause":"第6款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-07-29 15:04，「公告本公司第五屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-07-29-1501-81t2hm","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-07-29","time":"15:01:08","subject":"公告本公司一一四年第一次股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-07-29 15:01，「公告本公司一一四年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-07-29-1356-5rax5d","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-07-29","time":"13:56:32","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第11款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-07-29 13:56，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-07-29-1356-1jhewlf","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-07-29","time":"13:56:19","subject":"公告本公司公司治理主管異動","clause":"第8款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-07-29 13:56，「公告本公司公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-07-29-1355-9gq2ag","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-07-29","time":"13:55:50","subject":"睿生光電114年第二季合併財務報告","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-07-29 13:55，「睿生光電114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-07-29-1129-1tkkj4d","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-07-29","time":"11:29:49","subject":"公告本公司114年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-07-29 11:29，「公告本公司114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}